Pricing | |||||
5400 | |||||
3400 | |||||
1800 | |||||
Study Period | 2019-2030 |
Market Size (2023): | USD400Million |
Market Size (2030): | USD800Million |
CAGR (2023 - 2030): | 6.80% |
Fastest Growing Region | North America |
Dominating Region | Asia-Pacific |
Report Features |
Details |
Base Year |
2023 |
Based Year Market Size (2023) |
USD400Million |
Historical Period |
2019 to 2023 |
CAGR (2023 to 2030) |
6.80% |
Forecast Period |
2023 to 2030 |
Forecasted Period Market Size (2030) |
USD800Million |
Scope of the Report |
Segmentation by Type Antibodies, Segmentation by Application Drug Development, Cancer Research, Cell Death Research, Immunology, Clinical Trials, Sales Channel |
Regions Covered |
|
Companies Covered |
Enzo Life Sciences, Santa Cruz Biotechnology, R&D Systems, Abcam, Thermo Fisher Scientific, Bio-Rad, Merck, Biorad, PeproTech |
Customization Scope |
15% Free Customization (For EG) |
Delivery Format |
PDF and Excel through Email |